Syros Pharmaceuticals, a Cambridge, Mass.-based cancer drug developer, relied on Ten Bridge Communications and Stern IR for support through its July 6 IPO.
Syros raised $57.5M with the Nasdaq listing, short of projections. The funds will be used to fund its drug trials focused on controlling genes that cause cancer.
Ten Bridge partner Naoi Aoki leads the PR account at her firm, which was founded by Feinstein Kean Healthcare alums Dan Quinn and Ann Stanesa.
Stern senior associate Jesse Baumgartner reps Syros at the IR firm.
Prosek Partners handles New York’s Tilray Brands, craft beer & cannabis operation, as it acquires BrewDog, a leading British independent beer producer in the UK, for $45M.
Brunswick Group handles Zurich Insurance as it agrees to buy UK-based Beazley specialty insurer in a deal valued at $11B.
FGS Global represents Brink’s as it agrees to acquire NCR Atleos, which relies on Collected Strategies, in a $6.6B cash & stock deal to create a leading fintech infrastructure company. (Updated)
A January article in O’Dwyer’s proposes that in 2026, the strongest financial brands will not simply tell compelling stories—they will “signal readiness.”
C Street Advisory Group is working the Chapter 11 filing of Axip Energy Services as it unloads its nearly all of its assets to deal with a heavy debt load.
